BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20886197)

  • 1. Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis. Results from the OTIS-DVT Registry.
    Spirk D; Husmann M; Willenberg T; Banyai M; Frank U; Baldi T; Amann-Vesti B; Baumgartner I; Kucher N
    Thromb Haemost; 2011 Feb; 105(2):239-44. PubMed ID: 20886197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study.
    Parisi R; Visonà A; Camporese G; Verlato F; Lessiani G; Antignani PL; Palareti G
    Int Angiol; 2009 Feb; 28(1):68-72. PubMed ID: 19190559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
    Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
    J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient management of acute deep vein thrombosis: results from the OTIS-DVT registry.
    Spirk D; Banyai M; Jacomella V; Frank U; Baldi T; Baumgartner I; Amann-Vesti B; Kucher N; Husmann M
    Thromb Res; 2011 May; 127(5):406-10. PubMed ID: 21296385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current primary care practice in the diagnosis and management of patients with suspected venous thromboembolism and prescription of initiation dose of enoxaparin.
    Verhamme P; Motte S; Claes N; Verhaeghe R; Hermans C
    Int Angiol; 2010 Feb; 29(1):58-63. PubMed ID: 20224534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis for acute lower extremity deep venous thrombosis in a tertiary care setting.
    O'Connell JB; Chandra A; Russell MM; Davis G; Sanchez I; Lawrence PF; Derubertis BG
    Ann Vasc Surg; 2010 May; 24(4):511-7. PubMed ID: 20451794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.
    Prandoni P; Prins MH; Lensing AW; Ghirarduzzi A; Ageno W; Imberti D; Scannapieco G; Ambrosio GB; Pesavento R; Cuppini S; Quintavalla R; Agnelli G;
    Ann Intern Med; 2009 May; 150(9):577-85. PubMed ID: 19414836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study.
    Galanaud JP; Sevestre-Pietri MA; Bosson JL; Laroche JP; Righini M; Brisot D; Boge G; van Kien AK; Gattolliat O; Bettarel-Binon C; Gris JC; Genty C; Quere I;
    Thromb Haemost; 2009 Sep; 102(3):493-500. PubMed ID: 19718469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.
    East AT; Wakefield TW
    Semin Vasc Surg; 2010 Sep; 23(3):182-91. PubMed ID: 20826296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
    Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
    Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of anticoagulation: decision making based on absolute risk.
    Keeling D
    Blood Rev; 2006 May; 20(3):173-8. PubMed ID: 16271810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
    Heidenreich C; Hohmann V; Bramlage P
    Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.
    Lozano F; Trujillo-Santos J; Barrón M; Gallego P; Babalis D; Santos M; Falgá C; Monreal M;
    J Vasc Surg; 2014 May; 59(5):1362-7.e1. PubMed ID: 24439322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eligibility for home treatment of deep vein thrombosis: a prospective study in 202 consecutive patients.
    Schwarz T; Schmidt B; Beyer J; Schröder HE; Schellong SM
    J Vasc Surg; 2001 Dec; 34(6):1065-70. PubMed ID: 11743562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.
    Donadini MP; Ageno W; Antonucci E; Cosmi B; Kovacs MJ; Le Gal G; Ockelford P; Poli D; Prandoni P; Rodger M; Saccullo G; Siragusa S; Young L; Bonzini M; Caprioli M; Dentali F; Iorio A; Douketis JD
    Thromb Haemost; 2014 Jan; 111(1):172-9. PubMed ID: 24154729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism.
    Kearon C; Akl EA
    Blood; 2014 Mar; 123(12):1794-801. PubMed ID: 24497538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis.
    Reiff DA; Haricharan RN; Bullington NM; Griffin RL; McGwin G; Rue LW
    J Trauma; 2009 May; 66(5):1436-40. PubMed ID: 19430251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.